COMMUNIQUÉS West-GlobeNewswire

VALNEVA Announces Progress of Chikungunya Vaccine Candidate
16/10/2018
Valneva Announces Progress of Chikungunya Vaccine Candidate Saint Herblain (France), October 16, 2018 - Valneva SE ("Valneva" or "the Company"), a commercial stage biotech company focused on developing innovative [...]
VALNEVA annonce la progression du développement de son candidat vaccin contre le Chikungunya
16/10/2018
Valneva annonce la progression du développement de son candidat vaccin contre le Chikungunya Saint Herblain (France), 16 Octobre 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée au [...]
INNATE PHARMA : data presentations on monalizumab at the ESMO annual meeting 2018
16/10/2018
INNATE PHARMA ANNOUNCES DATA PRESENTATIONS ON MONALIZUMAB AT The european society for medical oncology ANNUAL MEETING 2018 Management to host KOL call on updated data from the ongoing Phase II trial of monalizumab and [...]
INNATE PHARMA : présentation de données pour monalizumab lors du congrès annuel ESMO
16/10/2018
INNATE PHARMA ANNONCE LA PRÉSENTATION DE DONNÉES POUR MONALIZUMAB LORS DU CONGRÈS ANNUEL DE LA SOCIÉTÉ EUROPÉENNE D'ONCOLOGIE MÉDICALE (ESMO) Une conférence téléphonique avec un leader d'opinion est organisée le lundi [...]
Probiodrug publishes SAPHIR data in peer reviewed journal
16/10/2018
Probiodrug publishes SAPHIR data in peer reviewed journal SAPHIR trial data published in Alzheimer's Research & Therapy HALLE (SAALE), Germany, 16 October 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical [...]
ICC Labs Provides Information About Circular
16/10/2018
VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. ( ICC or the Company ) (TSX-V: ICC) confirms that the management information circular dated October 3, 2018 (the Circular ), form of proxy and [...]
OpGen Provides Business and Preliminary Financial Update
15/10/2018
GAITHERSBURG, Md., Oct. 15, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today provided an update on its commercial activities and clinical trials for its Acuitas® AMR Gene Panel tests and the Acuitas Lighthouse [...]
Emblem Establishes Temporary “Patient Access Investment Fund” to Partially Cover Medical Cannabis Excise Tax
15/10/2018
Emblem will continue to advocate against the application of any tax on medical cannabis TORONTO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF ) ("Emblem" or the "Company") today announced that [...]
aTyr Pharma Announces Leadership Transition
15/10/2018
SAN DIEGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Emergent BioSolutions Completes Acquisition of Adapt Pharma and Flagship Product Narcan® (Naloxone HCI) Nasal Spray
15/10/2018
GAITHERSBURG, Md., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has completed its acquisition of Adapt Pharma and its flagship product NARCAN ® (naloxone HCl) Nasal [...]
B. Braun Premieres Its New Wireless Syringe Pump at NANN 2018
15/10/2018
BETHLEHEM, Pa., Oct. 15, 2018 (GLOBE NEWSWIRE) -- B. Braun Medical Inc., a leader in infusion therapy and pain management, will premiere the wireless 2nd generation software for its Perfusor ® Space Syringe Pump, at the [...]
GenMark Diagnostics Schedules Third Quarter Financial Results Conference Call for October 29, 2018
15/10/2018
CARLSBAD, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Monday, October 29, 2018. [...]
Aclaris Therapeutics to Acquire Worldwide Rights to RHOFADE® from Allergan
15/10/2018
WAYNE, Pa., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Pediapharm annonce la clôture de l’offre de reçus de souscription pour un produit brut total de 62 M$
15/10/2018
CE COMMUNIQUÉ NE PEUT ÊTRE DISTRIBUÉ AUX AGENCES DE TRANSMISSION AMÉRICAINES NI DIFFUSÉ AUX ÉTATS-UNIS. NE PAS RESPECTER CETTE CONSIGNE PEUT CONSTITUER UNE VIOLATION DE LA LOI SUR LES TITRES DES ÉTATS-UNIS. MONTRÉAL, 15 [...]
Welldoc Announces Expansion of Program with Leading Academic Medical Center to Evaluate BlueStar® Digital Therapeutic as a Means of Transforming Population Health in Primary Care
15/10/2018
COLUMBIA, Md., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Welldoc® today announced that one of the world’s leading academic medical centers is moving into Phase 2 for ongoing Quality Improvement research of BlueStar, its FDA- [...]
Sanofi: Disclosure of trading in own shares
15/10/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
15/10/2018
Pièce jointe Reporting FR.pdf
Ossur Hf : Transactions in relation to share buyback program
15/10/2018
Announcement no. 61/2018 15 October 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Diffusion Pharmaceuticals Chief Financial Officer William “Bill” Hornung to Present at 2018 BIO Investor Forum
15/10/2018
Over 1,000 Attendees Expected; Opportunity to Learn About Company’s FDA Approval for Phase 2 On-Ambulance Stroke Trial and Phase 3 GMB Brain Cancer Trial Enrollment CHARLOTTESVILLE, Va., Oct. 15, 2018 (GLOBE NEWSWIRE [...]

Pages